In a Form 4 filed earlier today, Cardiogenics Holdings Inc. CGNH Director, Neil Tabatznik, reported that he bought 600,000 shares of CGNH on December 2nd for an average price of $0.50.
The transaction totaled $300,000.
Mr. Tabatznik owns 2,482,534 direct shares of CGNH.
Source: The Washington Service
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in